Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: A Device Study for the Treatment of Acne [NA]
A completed clinical device trial for acne vulgaris with posted results.
-
FDA approval · 2023-10-20FDA Approved: CABTREO — Original Application (Bausch Health US LLC)
FDA approves CABTREO, a triple-combination topical acne medication containing clindamycin phosphate, benzoyl peroxide, and adapalene, for th…
-
FDA approval · 2023-10-13FDA Approved: DAPSONE — Original Application (Encube Ethicals, Inc.)
FDA approved Encube Ethicals, Inc.'s Original Application for DAPSONE GEL 5%, a topical dapsone formulation, as a generic product.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris [Phase 3]
Phase 3 trial evaluating minocycline hydrochloride foam for moderate-to-severe acne vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris. [Phase 2]
Phase 2 clinical trial evaluating topical BMX-010 for acne vulgaris was terminated; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-09-07FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Clindamycin Phosphate and Benzoyl Peroxide from Sun Pharmaceutical Industries.
-
FDA approval · 2023-08-29FDA Approved: ISOTRETINOIN — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves a generic isotretinoin product from Zydus Pharmaceuticals USA Inc. under an ANDA.
-
FDA approval · 2023-08-22FDA Approved: TRETINOIN — Original Application (Encube Ethicals, Inc.)
FDA approved the original application for tretinoin from Encube Ethicals, Inc., enabling a generic version of tretinoin.
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne [Phase 3]
Phase 3 trial assessing once-daily SB204 gel vs vehicle gel for acne vulgaris has completed with results posted.
-
FDA approval · 2023-07-18FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ABSORICA (isotretinoin) from Sun Pharmaceutical Industries.
-
FDA approval · 2023-07-18FDA Approved: ABSORICA LD — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ABSORICA LD (isotretinoin) from Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman. [Phase 3]
A phase 3 randomized double-blind trial evaluated the benefit of spironolactone for treating acne in adult women (Acne vulgaris).
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects [Phase 3]
Phase 3 long-term study of adapalene/benzoyl peroxide topical gel in acne vulgaris completed with results posted.
-
FDA approval · 2023-07-06FDA Approved: ADAPALENE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The U.S. FDA approved a supplemental application for Adapalene filed by Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne [Phase 1, Phase 2]
Clinical trial updates on pirfenidone combined with M-DDO gel for acne vulgaris, including superficial, mixed comedonal and inflammatory sub…
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Comparison of the Efficacy of Clindamycin Phosphate 1% Gel Versus Once-daily Dapsone 5% Gel in the Treatment of Moderate Acne Vulgaris [Phase 2]
Phase 2 trial comparing clindamycin phosphate 1% gel to once-daily dapsone 5% gel for moderate acne vulgaris has completed.
-
FDA approval · 2023-06-23FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)
FDA approved a supplemental application for isotretinoin from Mayne Pharma, extending or modifying the existing isotretinoin approval.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris [Phase 4]
A Phase 4 companion treatment study for patients with moderate to severe acne vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris [Phase 2]
Phase 2 trial evaluating imsidolimab (ANB019) for acne vulgaris has completed and its efficacy and safety results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Effect of New Topical Preparation for Treatment of Acne Vulgaris [Phase 2]
Phase 2 clinical trial update evaluating a new topical preparation for acne vulgaris, status unknown.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne [Phase 3]
Phase 3 trial comparing azelaic acid 15% gel versus vehicle in mild to moderate acne showed efficacy and safety data.
-
CLINICAL_TRIALS trial_result · 2023-06-06Clinical Trial Update: Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa [Phase 3]
Phase 3 trial update on an oral contraceptive for treating acne vulgaris completed.
-
FDA approval · 2023-06-06FDA Approved: DAPSONE — Original Application (Trupharma, LLC)
FDA approved the generic DAPSONE GEL, 5% (dapsone gel) from Trupharma, LLC under an Original Application (ANDA 213907).
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris [Phase 2]
A Phase 2 multi-center trial evaluating SB204 Gel for acne vulgaris has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: P3 Long Term Safety Study of Once Daily SB204 in Acne [Phase 3]
Phase 3 long-term safety study of once-daily SB204 in acne vulgaris completed; results posted.